New opportunities for the development of cancer immunotherapies.
Rosenberg
S A
SA
Surgery Branch, National Cancer Institute, Bethesda, MD 10892-1502, USA.
D000595:Amino Acid Sequence; D000951:Antigens, Neoplasm / Q000737:chemistry / Q000276:immunology; D000939:Epitopes / Q000737:chemistry; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D007376:Interleukin-2 / Q000627:therapeutic use; D016246:Lymphocytes, Tumor-Infiltrating; D008545:Melanoma / Q000276:immunology / Q000628:therapy; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000628:therapy*; D014481:United States
D000951:Antigens, Neoplasm; D000939:Epitopes; D007376:Interleukin-2